A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
BeiGene
Eli Lilly and Company
National Cancer Institute, Naples
National Cancer Institute, Naples
European Organisation for Research and Treatment of Cancer - EORTC
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
The Netherlands Cancer Institute
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
AIO-Studien-gGmbH
National University Hospital, Singapore
The University of Texas Health Science Center, Houston
Amgen
Dong-A University Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Royal Marsden NHS Foundation Trust
University Hospital of Crete
Fudan University
Merck KGaA, Darmstadt, Germany
Sun Yat-sen University
Pomeranian Medical University Szczecin
Providence Health & Services
National Cancer Center, Korea
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Johannes Gutenberg University Mainz